These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 7588352)

  • 1. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
    Barbaro G; Barbarini G; Di Lorenzo G
    Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G; Di Lorenzo G
    Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
    Barbaro G; Barbarini G; Di Lorenzo G
    Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G; Barbarini G; Di Lorenzo G
    Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
    de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
    Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes].
    Gil A; Lavilla P; López Dupla M; Valencia E; Pintado V; Khamashta M; García Puig J; Ortiz-Vázquez J
    Med Clin (Barc); 1992 Apr; 98(16):612-7. PubMed ID: 1630165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
    Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
    Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
    Brockmeyer NH; Hantschke D; Olbricht T; Hengge UA; Goos M
    Mycoses; 1991; 34 Suppl 1():83-6. PubMed ID: 1818270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The therapy of Candida esophagitis in AIDS patients with fluconazole].
    Heise W; Arasteh K; L'age M
    Mycoses; 1990; 33 Suppl 1():32-6. PubMed ID: 2101862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
    Bozzette SA; Larsen RA; Chiu J; Leal MA; Jacobsen J; Rothman P; Robinson P; Gilbert G; McCutchan JA; Tilles J
    N Engl J Med; 1991 Feb; 324(9):580-4. PubMed ID: 1992319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
    Parente F; Ardizzone S; Cernuschi M; Antinori S; Esposito R; Moroni M; Lazzarin A; Bianchi Porro G
    Am J Gastroenterol; 1994 Mar; 89(3):416-20. PubMed ID: 8122656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection.
    Manfredi R; Mastroianni A; Coronado OV; Chiodo F
    Arch Intern Med; 1997 Jan; 157(1):64-9. PubMed ID: 8996042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.
    Stevens DA; Greene SI; Lang OS
    Arch Intern Med; 1991 Dec; 151(12):2458-64. PubMed ID: 1747004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Esophageal pathology in patients with the AIDS virus. Etiology and diagnosis].
    Varsky CG; Yahni VD; Freire MC; Patrizio E; Balbo V; Benetucci J; Boffi A; Mattoni RA; Luis ; Alicia M
    Acta Gastroenterol Latinoam; 1991; 21(2):67-83. PubMed ID: 1820692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases.
    López-Dupla M; Mora Sanz P; Pintado García V; Valencia Ortega E; Uriol PL; Khamashta MA; Aguado AG
    Am J Gastroenterol; 1992 Dec; 87(12):1771-6. PubMed ID: 1449139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.
    de Wet NT; Bester AJ; Viljoen JJ; Filho F; Suleiman JM; Ticona E; Llanos EA; Fisco C; Lau W; Buell D
    Aliment Pharmacol Ther; 2005 Apr; 21(7):899-907. PubMed ID: 15801925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
    Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
    Parente F; Bianchi Porro G
    Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.